No Data
No Data
Sai Sheng Pharmaceutical (06600.HK): The expected revocation of stock listing status will take effect on July 5th.
On June 19, Gralon released an announcement that the expected revocation of the company's listing status in the Stock Exchange of Hong Kong Limited will take place at 4 pm on July 5, 2024, after the plan becomes effective. After the plan becomes effective, the trading unit of the stock will be changed from 500 shares per lot to 800,000 shares per lot, effective from July 3, 2024.
Express News | SciClone Pharmaceuticals (Holdings) - Scheme Is Expected to Become Effective on 3 July 2024
Express News | SciClone Pharmaceuticals (Holdings) - Proposal for Privatisation of SciClone Pharmaceuticals (Holdings) by Silver Pegasus Investment
The 12,500 stock options granted by Saisheng Pharmaceutical have expired.
Saisheng Pharmaceutical (06600) announced that on June 15, 2024, 12,500 share purchase rights granted under the first public offering of shares after the share-purchase plan became invalid according to the rules of the plan.
Saisei Pharmaceuticals (06600): 12,500 share purchase rights have expired.
Zhitong Finance App News, Saisheng Pharmaceutical (06600) announced that on June 15, 2024, 12,500 share purchase rights granted under the first public offering after purchase of shares plan have expired in accordance with the rules of the plan.
Saishi Pharmaceutical (06600): 207,900 share purchase rights have been exercised.
Zhixun Finance APP News, Saiseng Pharmaceutical (06600) released an announcement that on June 7, 2024, 207,900 share purchase rights granted under the first public offering after purchase equity plan have been exercised in accordance with the rules of the first public offering after purchase equity plan.
No Data